Polyvinyl Alcohol Eye Drops 1,4 % w/v

Manufacturer
Aurolab
Effective date
2024-12-23
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 00:48:15

Label at a glance#

ProductPolyvinyl Alcohol Eye Drops 1,4 % w/v
Active ingredientPOLYVINYL ALCOHOL, UNSPECIFIED
Label structure14 sections

Dosage and administration

lnstill 1or 2 drops in the affected eye, as needed

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Polyvinyl Alcohol Eye Drops 1.4 % w/v

DIRECTIONS FOR USE

INSTRUCTIONS FOR USE SECTION

  • lnstill 1or 2 drops in the affected eye, as needed

INACTIVE INGREDIENT

INACTIVE INGREDIENT SECTION

1.Boric acid

2.Calcium chloride

3.Glycerin
4.Magnesium chloride

5.Mannitol

6.Potassium chloride

7.Purified water

8.Stablized oxy cholro complex

9.Sodium tetra borate
10.Sodium hyaluronate

11.Sodium citrate

Tamper Protection

OTHER SAFETY INFORMATION

  • For your protection a tamper evident ring is attached to the bottlecap
  • Upon opening, this will separate from the cap and can be discarded
  • Use only if this ring is present and attached when the bottle is first opened

Use

INDICATIONS & USAGE SECTION

For use as a lubricant to prevent further irritation or to relieve dryness of the eye

Questions

OTC - QUESTIONS SECTION

Call. 1-800-103-7321
E-mail : info@aurolab.com
Web : www.aurolab.com

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed get medical help or contact a Poison Control Center right away

Stop use and ask a doctor if

OTC - ASK DOCTOR SECTION

  1. If you experience eye pain
  2. change in vision
  3. Continued Redness or irritaion of teh eye
  4. Condition worsens or persists for mroe than 72 hours

Do not use

OTC - DO NOT USE SECTION

1.If you are sensitive to any ingredient in this product
2.If solution changes color or becomes cloudy

Warnings

WARNINGS SECTION

For external use only

Indication & usage

INDICATIONS & USAGE SECTION

Do not touch the nozzle tip to any surface since this may contaminate the solution
Remove contact lenses before use Should not use at the same time as other ophthalmic drugs
Replace cap after using

Dose

DOSAGE & ADMINISTRATION SECTION

Instill 1 or 2 drops in the affected eyes as needed

Eye lubricant

OTC - PURPOSE SECTION

Eye lubricant

Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PVAPVA

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
16030-201-10Polyvinyl Alcohol Eye Drops 1,4 % w/v10 mL in 1 BOTTLE, DROPPERFOR SOLUTION104

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
16030-201POLYVINYL ALCOHOL EYE DROPS 1,4 % W/V FOR SOLUTION [AUROLAB]4Current NDC, Legacy NDC, 1 package rows20241224_ec5cf186-f141-4377-e053-2995a90a6b32.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
16030-20116030-201-10

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Polyvinyl Alcohol Eye Drops 1,4 % w/vPOLYVINYL ALCOHOL EYE DROPS 1,4 % W/VAurolabe8e09719-6e06-612b-e053-2995a90a79fc2026-01-08WarningsExact identifier
ndc (product): 16030-201
29ed39d7-180f-93e4-e063-6294a90a73a9ec5cf186-f141-4377-e053-2995a90a6b322024-12-23WarningsExact identifier
spl id: 29ed39d7-180f-93e4-e063-6294a90a73a9
spl set id: ec5cf186-f141-4377-e053-2995a90a6b32

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.